1st Quarter - Report

RETIRESAFE for RETIRESAFE

Firm
Client
Income
—
Expenses
$68,787
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Lobbied the House and Senate to encourage a change in the bundled surgical payments to allow non-opioid pain solutions to be included.

LobbyistCovered position, as disclosed
THAIR PHILLIPS —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.

LobbyistCovered position, as disclosed
MARK GIBBONS New —
THAIR PHILLIPS —

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 4710 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.